Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

TCF19 Inhibitors

TCF19 inhibitors are a class of chemical compounds designed to specifically inhibit the activity of the transcription factor TCF19. TCF19, or Transcription Factor 19, plays a significant role in the regulation of gene expression, particularly during the cell cycle and processes involved in cellular proliferation. As a member of the transcription factor family, TCF19 binds to specific DNA sequences in the promoter regions of its target genes, influencing their transcriptional activity. TCF19 is known to regulate genes that are crucial for cellular growth, division, and the maintenance of normal cell functions. By inhibiting TCF19, these compounds prevent its binding to DNA, thereby altering the expression of genes that it controls, which may lead to changes in cellular dynamics, especially those related to proliferation and cell cycle progression.

Research into TCF19 inhibitors provides valuable insights into the role of TCF19 in maintaining cellular homeostasis and regulating critical phases of the cell cycle. By blocking the activity of TCF19, scientists can study how changes in gene expression affect cellular processes such as DNA replication, mitosis, and cellular growth. These inhibitors allow researchers to explore the function of TCF19 in various contexts, such as how it contributes to the coordination of transcriptional programs during different stages of the cell cycle. Additionally, TCF19 inhibitors are useful tools for investigating the broader mechanisms of transcription factor regulation and how specific transcription factors interact with other proteins to orchestrate complex gene regulatory networks. Overall, the study of TCF19 inhibitors deepens our understanding of transcriptional control in cellular proliferation and the molecular mechanisms that govern cell cycle regulation and gene expression.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine may downregulate TCF19 expression by inducing hypomethylation of its gene promoter, which can lead to transcriptional repression of the gene.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

As a histone deacetylase inhibitor, Trichostatin A could decrease TCF19 expression by altering chromatin compaction, thus hindering the initiation of transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid might reduce TCF19 expression by promoting a more closed chromatin state, thereby obstructing the binding of transcription machinery to the TCF19 gene.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid could suppress TCF19 expression by binding to nuclear receptors that repress the transcription of specific target genes, including TCF19.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

By binding to specific DNA sequences, Mithramycin A possibly could inhibit the transcriptional initiation of TCF19 by blocking essential transcription factor sites.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine might lead to a reduction in TCF19 expression by DNA demethylation, resulting in transcriptional silencing of the gene.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin could indirectly lead to a decrease in TCF19 expression by inhibiting the mTOR pathway, which is involved in the regulation of protein synthesis.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D could inhibit TCF19 expression by intercalating into DNA and preventing the elongation phase of RNA transcription by RNA polymerase.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Through the activation of protein kinase C, PMA could lead to a decrease in TCF19 expression by altering the activity of transcription factors that control the gene's expression.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Doxorubicin could downregulate TCF19 expression by intercalating DNA and inhibiting the topoisomerase II enzyme, disrupting the transcription process of the gene.